Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593378 | SCV000708906 | uncertain significance | not provided | 2017-06-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000593378 | SCV002173700 | likely benign | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532655 | SCV003531552 | uncertain significance | Inborn genetic diseases | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.17869G>A (p.A5957T) alteration is located in exon 84 (coding exon 84) of the ADGRV1 gene. This alteration results from a G to A substitution at nucleotide position 17869, causing the alanine (A) at amino acid position 5957 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |